Excerpt from today's press release -- "The Company's focus is to provide services and technologies to facilitate the efficient acquisition and delivery of purified adult stem cells" There will be little if any resistance (particularly in terms of funding) to the development of "adult stem cells" http://www.freerepublic.com/focus/f-news/1319318/posts
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.